Pharmacodynamic (kinetic) considerations in the treatment of moderately severe infections with cefotaximeTURNIDGE, J. D.Diagnostic microbiology and infectious disease. 1995, Vol 22, Num 1-2, pp 57-69, issn 0732-8893Conference Paper

Post-antibiotic growth suppression of linezolid against Gram-positive bacteriaMUNCKHOF, W. J; GILES, C; TURNIDGE, J. D et al.Journal of antimicrobial chemotherapy (Print). 2001, Vol 47, Num 6, pp 879-883, issn 0305-7453Article

The postantibiotic effect of fusidic acid against gram-positive bacteriaMUNCKHOF, W. J; TURNIDGE, J. D.Journal of antimicrobial chemotherapy (Print). 1997, Vol 40, Num 3, pp 433-436, issn 0305-7453Article

The postantibiotic effect of imipenem : Relationship with drug concentration, duration of exposure, and MICMUNCKHOF, W. J; OLDEN, D; TURNIDGE, J. D et al.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 8, pp 1735-1737, issn 0066-4804Article

The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in childrenROWLAND, K. E; TURNIDGE, J. D.Australian and New Zealand journal of medicine. 2000, Vol 30, Num 4, pp 441-449, issn 0004-8291Conference Paper

The pharmacodynamics of β-lactamsTURNIDGE, J. D.Clinical infectious diseases. 1998, Vol 27, Num 1, pp 10-22, issn 1058-4838Conference Paper

Disc susceptibility testing for thermomphilic campylobactersHUYSMANS, M. B; TURNIDGE, J. D.Pathology (Sydney). 1997, Vol 29, Num 2, pp 209-216, issn 0031-3025Article

Home-based treatment of cellulitis with twice-daily cefazolinLEDER, K; TURNIDGE, J. D; GRAYSON, M. L et al.Medical journal of Australia. 1998, Vol 169, Num 10, pp 519-522, issn 0025-729XArticle

Neurological complications of chlamydial infections: Case report and reviewKORMAN, T. M; TURNIDGE, J. D; GRAYSON, M. L et al.Clinical infectious diseases. 1997, Vol 25, Num 4, pp 847-851, issn 1058-4838Article

Investigation of hematuria at a printing companySINCLAIR, M. I; MCNEIL, J. J; ATKINS, R. C et al.Journal of occupational medicine. 1993, Vol 35, Num 10, pp 1055-1061, issn 0096-1736Article

Risk factors for adverse cutaneous reactions associated with intravenous vancomycinKORMAN, T. M; TURNIDGE, J. D; GRAYSON, M. L et al.Journal of antimicrobial chemotherapy (Print). 1997, Vol 39, Num 3, pp 371-381, issn 0305-7453Article

Evaluation of API campy in comparison with conventional methods for identification of thermophilic campylobactersHUYSMANS, M. B; TURNIDGE, J. D; WILLIAMS, J. H et al.Journal of clinical microbiology (Print). 1995, Vol 33, Num 12, pp 3345-3346, issn 0095-1137Article

Acute epiglottitis in adultsLOVE, J. B; PHELAN, D. M; RUNCIMAN, W. B et al.Anaesthesia and intensive care. 1984, Vol 12, Num 3, pp 264-269, issn 0310-057XArticle

The postantibiotic effect of antifungal agents against common pathogenic yeastsTURNIDGE, J. D; GUDMUNDSSON, S; VOGELMAN, B et al.Journal of antimicrobial chemotherapy (Print). 1994, Vol 34, Num 1, pp 83-92, issn 0305-7453Article

Evolution of resistance in Staphylococcus aureus in Australian teaching hospitals : Infectious diseases : an Australian perspectiveTURNIDGE, J. D; NIMMO, G. R; FRANCIS, G et al.Medical journal of Australia. 1996, Vol 164, Num 2, pp 68-71, issn 0025-729XArticle

Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitroMIDOLO, P. D; TURNIDGE, J. D; LAMBERT, J. R et al.Journal of antimicrobial chemotherapy (Print). 1997, Vol 39, Num 3, pp 331-337, issn 0305-7453Article

Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the National Committee for Clinical Laboratory standards methodCOUTANT, C; OLDEN, D; BELL, J et al.Diagnostic microbiology and infectious disease. 1996, Vol 25, Num 1, pp 9-13, issn 0732-8893Article

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided dosesMUNCKHOF, W. J; GRAYSON, M. L; TURNIDGE, J. D et al.Journal of antimicrobial chemotherapy (Print). 1996, Vol 37, Num 4, pp 645-663, issn 0305-7453Article

Dissemination and genetic context analysis of bla_VIM-6 among Pseudomonas aeruginosa isolates in Asian-Pacific NationsCASTANHEIRA, M; BELL, J. M; TURNIDGE, J. D et al.Clinical microbiology and infection. 2010, Vol 16, Num 2, pp 186-189, issn 1198-743X, 4 p.Article

Rapidly emerging antimicrobial resistances in Streptococcus pneumoniae in AustraliaTURNIDGE, J. D; BELL, J. M; COLLIGNON, P. J et al.Medical journal of Australia. 1999, Vol 170, Num 4, pp 152-155, issn 0025-729XArticle

Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756BELL, J. M; TURNIDGE, J. D; JONES, R. N et al.International journal of antimicrobial agents. 2002, Vol 19, Num 2, pp 125-132, issn 0924-8579Article

Antimicrobial resistance testing of Helicobacter pylori : A comparison of etest and disk diffusion methodsMIDOLO, P. D; BELL, J. M; LAMBERT, J. R et al.Pathology (Sydney). 1997, Vol 29, Num 4, pp 411-414, issn 0031-3025Article

Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitroMIDOLO, P. D; TURNIDGE, J. D; LAMBERT, J. R et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 6, pp 1531-1533, issn 0066-4804Article

Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific Region clinical isolates from the SENTRY program, 1999 to 2001CHRISTIANSEN, K. J; BELL, J. M; TURNIDGE, J. D et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 6, pp 2049-2055, issn 0066-4804, 7 p.Article

Prevalence of extended-spectrum β-lactamase-producing enterobacter cloacae in the Asia-Pacific region: Results from the SENTRY antimicrobial surveillance program, 1998 to 2001BELL, J. M; TURNIDGE, J. D; JONES, R. N et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 12, pp 3989-3993, issn 0066-4804, 5 p.Article